Regeneron vs Amgen: Does The Patent Battle Even Matter?
June 06, 2017 at 15:03 PM EDT
The battle between Amgen and Regeneron over the patent for a new cholesterol drug continues. An appeals court hearing is underway with Regeneron hoping to overturn a lower court ruling that favored its rival. On a break from the proceedings, one analyst offers up his observations.
